Our leadership team is made up of individuals who are the top minds in their fields and who have paved the way for the work that Emily’s Entourage is doing.
Owner, Osage Partners
Bob founded Osage Partners in 1990 and has built a track record as a top-performing venture investor. He is a native of Tulsa, Oklahoma, where he is a partner in a fourth generation family business. Prior to founding Osage, Bob clerked with the honorable Walter K. Stapleton, U.S. Third Circuit Court of Appeals, and practiced corporate law at the Philadelphia law firm of Wolf, Block, Schorr & Solis-Cohen. He is a graduate of The Yale Law School, where he was an editor of The Yale Law Journal, and of Yale College, from which he graduated summa cum laude.
Bob is a trustee of Thomas Jefferson University, where he chairs the Innovation Pillar, and is a former Chair of Thomas Jefferson University Hospital and trustee of its former parent, Jefferson Health System. He serves on the Board of Directors of the Free Library of Philadelphia Foundation, is a member of the Advisory Council of the Yale Entrepreneurial Institute and serves on the Investment Committee of the Philadelphia Museum of Art and on the Business Development Committee of The Wistar Institute. Bob has served as a past member of The Yale Law School Fund, as a trustee of the Board of Friends Central School and as a former President of the Board of Trustees of The Philadelphia School.
Bob has been a board member of several private companies, and currently is on the boards of Halfpenny Technologies and Collections Marketing Center. Bob and his wife Marta reside in Merion, PA. They have three grown children.
Co-President of GBG Kids
Mark Fishman is the co-president of GBG Kids, (formerly Fishman & Tobin, Inc.) a Philadelphia based clothing manufacturing company. Fishman & Tobin was a family owned business started in 1914 and was sold at the end of 2011 to Li and Fung.
Today, the company sells to every major retailer in the United States, including Wal-Mart, Sears, Macys JCPenney, Federated, and Dillard’s to name a few. Mark came to the firm in 1978 and held a variety of positions and became president in 1985. He assumed the role of Chairman in 2005.
Mark has served on the board of The Children’s Hospital of Philadelphia for over 30 years. He is currently on the Foundation Board of Overseers at CHOP and is co-chairing the upcoming capital campaign. Mark also serves on the Board of Visitors of Duke University for the past 17 years. Other boards include the Brodsky Research Institute at Johns Hopkins, the Center for Leadership and Learning (CLAL) in New York, Atidim Board for educational charities based in Israel. He is also a Lifetime Trustee at Federation of Jewish Agencies of Greater Philadelphia and current Vice President.
Chair, Department of Physiology
Isaac Ott Professor of Physiology
Perelman School of Medicine, University of Pennsylvania
J. Kevin Foskett, PhD, is the Isaac Ott Professor of Physiology and Chair of the Department of Physiology in the Perelman School of Medicine at the University of Pennsylvania. He is also Professor in the Department of Cell and Developmental Biology, and a member of the Mahoney Institute for Neurosciences and the Abramson Cancer Center. Dr. Foskett has been a stalwart member of Penn Medicine for nearly 20 years. After earning his doctorate at the University of California, Berkeley, he held positions at Toronto’s Hospital for Sick Children and at the University of Toronto before coming to Penn.
Dr. Foskett’s research for over 30 years has focused on the mechanisms and regulation of ion transport and signal transduction. He has had long standing interest in exocrine epithelial ion and water transport, with a particular focus on the genetic disease cystic fibrosis, and has published extensively on various aspects of the biophysics and cell biology of CFTR and the cell biology of lung submucosal glands, the site of the primary defect in the lungs in CF. He served as a consultant to the Cystic Fibrosis Foundation in their collaboration with Aurora Biosciences/Vertex that directly led to the development of the first drug that targets the basic defect in cystic fibrosis.
Co-Founder of Emily’s Entourage
President of PerformCare
Michael graduated with a BA in psychology from Colgate University. He then earned a PhD in Developmental and Clinical Psychology from the University of Illinois-Chicago. He completed a pre- and post-doctoral internship at the New York Hospital-Cornell Medical Center-Westchester Division. Michael then completed the Executive MBA program at the Wharton School of the University of Pennsylvania.
Michael has been a clinical psychologist for over 30 years. He has spent the past 20 of them as a business executive running large national organizations with a focus on helping individuals receive high quality care. Currently Michael is the President of PerformCare, a national behavioral health company assisting Medicaid recipients.
Michael is a founding member of Emily’s Entourage and the proud father of Emily, Coby, Julia and Annie.
Scientific Director of Emily’s Entourage
Co-Founder of Emily’s Entourage
Liza graduated from Colgate University in 1978. She received her master’s degree in social work from the Jane Addams School of Social Work at the University of Illinois.
Before leaving the professional workforce to raise four kids, Liza worked as a teacher and at a variety of social service agencies helping children and families with special needs and delinquency. She had a particular interest in at-risk juveniles and worked closely with the juvenile court system.
Since co-founding Emily’s Entourage in 2011, Liza has worked tirelessly to help run and oversee all aspects of the foundation.
Liza is the proud mother of Emily, Coby, Julia and Annie
Co-Founder of Emily’s Entourage
Emily Kramer-Golinkoff, a 32-year-old with advanced stage Cystic Fibrosis, is Co-Founder of Emily’s Entourage and an internationally recognized patient advocate and speaker.
Named a White House Precision Medicine “Champion of Change,” Emily has given talks at The White House, TEDx, University of Pennsylvania’s Annenberg School for Communication graduation, and Stanford University’s Medicine X conference. Her story has been featured on CNN.com, People.com, Time.com, Yahoo Health, AOL, CBS’s The Doctors, and more. She is the recipient of the Global Genes 2016 Rare Champion of Hope for Advocacy Award.
Emily has a master’s degree in bioethics and certification in clinical ethics mediation from the University of Pennsylvania, where she also completed her undergraduate degree.
Deloitte Global Life Sciences & Health Care Leader
Greg is a principal at Deloitte Consulting LLP and leads the Firm’s US Life Sciences Consulting practice. In his role he is responsible for the delivery of all consulting services to the portfolio of life sciences clients, practice operations and the development of solutions, methods and research related to the transformation of life sciences companies.
Greg has more than 25 years of experience in the life sciences, process manufacturing, consumer and government sectors. His consulting career has spanned such topics as technology strategy, integration solution development and implementation of emerging and disruptive technology. His clients have included multinational pharmaceutical, biotechnology and chemical manufacturing organizations where he successfully led consulting services in support of regulatory, clinical, commercialization and manufacturing operations.
Prior to his consulting career Greg held positions at a government research lab, where he led teams in the design and development of life support devices; and was a lecturer at the University of Pennsylvania.
Greg holds an MS from the University of Pennsylvania, and a BSME from Drexel University
Executive Vice President, The Wistar Institute; Director – Wistar Vaccine Center; W.W. Smith Charitable Trust Professor in Cancer Research
Preeminent immunologist and vaccine expert, David B. Weiner, Ph.D., is executive vice president of The Wistar Institute, director of the Wistar Vaccine Center, and the W. W. Smith Charitable Trust Professor in Cancer Research. Dr. Weiner directs a translational research laboratory in the area of Molecular Immunology. His group is one of the pioneering research teams in establishing the field of DNA vaccines and immune therapies. Important reports from his lab include the first DNA vaccine studied for HIV as well as for cancer immune therapy, the early development of DNA encoded genetic adjuvants including the particularly relevant IL-12, advances in gene optimization, and advances in electroporation technologies resulting in improved gene delivery among others. His group worked with collaborators to become the first to move DNA technology into human study. His laboratory’s work helped revitalize the field through advancement of new synthetic DNA design and modification of EP delivery approaches resulting in potent immune induction as well as the first successful Phase IIb DNA efficacy study (for HPV immune therapy) in humans.
Weiner is the recipient of numerous honors including election as a fellow to both the American Association for the Advancement of Science in 2011 and the International Society for Vaccines in 2012. He is the recipient of the NIH Director’s Transformative Research Award and received the Vaccine Industry Excellence Award for Best Academic Research Team in 2015 at the World Vaccine Congress. Weiner was honored with the prestigious Hilleman Lectureship in 2015 at the Children’s Hospital of Philadelphia Grand Rounds session and received a Stone Family Award from Abramson Cancer Center for his groundbreaking work on DNA vaccines for cancer immune therapy.
In March 2016, Weiner returned to Wistar from his position at The University of Pennsylvania School of Medicine as professor of Pathology and Laboratory Medicine. From 1990 to 1993, Weiner held a joint position as assistant professor of Pathology and Laboratory Medicine at The Wistar Institute and the University of Pennsylvania School of Medicine.
Weiner graduated with a B.S. in biology from SUNY at Stony Brook, in Stony Brook, N.Y., a M.S. in biology from the University of Cincinnati and a Ph.D. in developmental biology from the University of Cincinnati College of Medicine.